LRIG1 controls proliferation of adult neural stem cells by facilitating TGFβ and BMP signalling pathways.
Stephanie OuzikovKyshona M EdwardsTanvi AnandampillaiSamuel WatanabeDaniela Lozano CasasbuenasKaren K SiuDanyon HarkinsAaron DouDanielle JeongJeffrey E LeeScott A YuzwaPublished in: Communications biology (2024)
Adult Neural Stem Cells (aNSCs) in the ventricular-subventricular zone (V-SVZ) are largely quiescent. Here, we characterize the mechanism underlying the functional role of a cell-signalling inhibitory protein, LRIG1, in the control of aNSCs proliferation. Using Lrig1 knockout models, we show that Lrig1 ablation results in increased aNSCs proliferation with no change in neuronal progeny and that this hyperproliferation likely does not result solely from activation of the epidermal growth factor receptor (EGFR). Loss of LRIG1, however, also leads to impaired activation of transforming growth factor beta (TGFβ) and bone morphogenic protein (BMP) signalling. Biochemically, we show that LRIG1 binds TGFβ/BMP receptors and the TGFβ1 ligand. Finally, we show that the consequences of these interactions are to facilitate SMAD phosphorylation. Collectively, these data suggest that unlike in embryonic NSCs where EGFR may be the primary mechanism of action, in aNSCs, LRIG1 and TGFβ pathways function together to fulfill their inhibitory roles.
Keyphrases
- transforming growth factor
- epidermal growth factor receptor
- neural stem cells
- epithelial mesenchymal transition
- tyrosine kinase
- signaling pathway
- mesenchymal stem cells
- small cell lung cancer
- bone regeneration
- heart failure
- left ventricular
- stem cells
- single cell
- bone mineral density
- machine learning
- young adults
- cell therapy
- bone marrow
- body composition
- small molecule
- artificial intelligence
- atrial fibrillation
- postmenopausal women
- cerebral ischemia
- radiofrequency ablation
- childhood cancer
- subarachnoid hemorrhage